Paula A. Lengerke-Diaz

Smartphone based on-chip fluorescence imaging and capillary flow velocity measurement for detecting ROR1+ cancer cells from buffy coat blood samples on dual-layer paper microfluidic chip

Tiffany-Heather Ulep, Ryan Zenhausern, Alana Gonzales et al. · Biosensors and Bioelectronics · 2020 · 49 citations · Full text

Engineering, Ror1+ Cancer Cells, Biomedical Imaging +10

Validation of VIRSTA and Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT) Scores to Determine the Priority of Echocardiography in Patients With <i>Staphylococcus aureus</i> Bacteremia

Juan Sebastián Peinado-Acevedo, Juan José Hurtado-Guerra, Carolina Hincapié et al. · Clinical Infectious Diseases · 2020 · 29 citations

Ibrutinib reduces obinutuzumab infusion-related reactions in patients with chronic lymphocytic leukemia and is associated with changes in plasma cytokine levels

Juliana Vélez Luján, Paula A. Lengerke-Diaz, C Jacobs et al. · Haematologica · 2019 · 14 citations · Full text

Hematological Malignancy, Autoimmune Disease, Obinutuzumab Infusion-related Reactions +12

Incidence of thrombosis in relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucel: Mayo Clinic experience

Megan Melody, Sangeetha Gandhi, Hollie Saunders et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2022 · 13 citations

Immunology, Pathology, Pharmacotherapy +17

Predictors and Management of Relapse to Axicabtagene Ciloleucel in Patients with Aggressive B-cell Lymphoma ☆

José Vicente Forero-Forero, Paula A. Lengerke-Diaz, Eider Moreno-Cortes et al. · Hematology/Oncology and Stem Cell Therapy · 2021 · 11 citations · Full text